Table 3.
Univariate analysis of recurrence among ovarian endometriotic disease patients using Cox regression model
| Variables | OR | 95% CI | P |
|---|---|---|---|
| Age | 0.749 | 0.401–1.398 | 0.364 |
| < or ≥47 years | |||
| Gravidity times | 0.912 | 0.465–1.788 | 0.789 |
| ≤ or >1 | |||
| Parity times | 1.481 | 0.519–4.229 | 0.463 |
| ≤ or >1 | |||
| Menopause | 0.327 | 0.044–2.442 | 0.276 |
| Yes or no | |||
| Tumor diameter | 1.109 | 0.599–2.052 | 0.742 |
| < or ≥6 cm | |||
| CA125 (U/L) | 1.477 | 0.712–3.060 | 0.295 |
| Normal or not | |||
| Other benign disease | 0.782 | 0.405–1.509 | 0.463 |
| Yes or no | |||
| Endometrial disorders | 1.276 | 0.927–1.757 | 0.135 |
| Yes or no | |||
| Postoperative medication | 2.087 | 1.093–3.985 | 0.026 |
| Yes or no | |||
| Ovarian preservation | 6.015 | 2.142–16.889 | 0.001 |
| Yes or no | |||
| Uterine preservation | 1.839 | 0.988–3.408 | 0.055 |
| Yes or no | |||
| rAFS stage | 1.551 | 0.788–3.052 | 0.204 |
| I–II or III–IV |
rAFS: Revised American Fertility Society classification system; OR: Odds ratio; CI: Confidence interval.